Last reviewed · How we verify

GRT7041 MAD

Grünenthal GmbH · Phase 1 active Small molecule

At a glance

Generic nameGRT7041 MAD
SponsorGrünenthal GmbH
ModalitySmall molecule
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results